Results 251 to 260 of about 56,165 (274)

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Lancet, The, 2018
Craig M Mcdonald, Paula R Clemens, Heather Gordish-Dressman   +2 more
exaly  

Influencing the process of muscular dystrophy in animal models

Clinical Neurology and Neurosurgery, 1984
P. Wirtz, H. Loermans
openaire   +1 more source

Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study

Lancet, The, 2011
Sebahattin Cirak, V Arechavala-Gomeza, Michela Guglieri   +2 more
exaly  

The Validity of Animal Studies with Chemical Carcinogens

Ca-A Cancer Journal for Clinicians, 1981
exaly  

Efficacy of idebenone on respiratory function in patients with Duchenne muscular dystrophy not using glucocorticoids (DELOS): a double-blind randomised placebo-controlled phase 3 trial

Lancet, The, 2015
Thomas Voit, Janbernd Kirschner, Richard S Finkel   +2 more
exaly  

Immunologic Factors Involved in the Growth of Primary Tumors in Human or Animal Hosts

Ca-A Cancer Journal for Clinicians, 1970
exaly  

Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification

Toxicologic Pathology, 2017
Crystal Faelan
exaly  

Duchenne muscular dystrophy: Animal models and genetic manipulation

Neuromuscular Disorders, 1992
openaire   +1 more source

Advances in Duchenne muscular dystrophy gene therapy

Nature Reviews Genetics, 2003
Gert-Jan B Van Ommen
exaly  

NUTRITIONAL MUSCULAR DYSTROPHY AND HUMAN MYOCARDIAL INFARCTION

Lancet, The, 1973
exaly